Viewing Study NCT02596503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-02-23 @ 9:16 PM
Study NCT ID: NCT02596503
Status: COMPLETED
Last Update Posted: 2022-02-15
First Post: 2015-10-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors
Sponsor: University of Colorado, Denver
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 15-0659.cc
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View